Alidjinou E K, Bocket L, Pigot V, Lambert V, Hallaert C, Canva V, Hober D
Univ Lille, Faculté de Médecine, CHU Lille, Laboratoire de Virologie EA3610, F-59000, Lille, France.
Univ Lille, Faculté de Médecine, CHU Lille, Laboratoire de Virologie EA3610, F-59000, Lille, France.
Diagn Microbiol Infect Dis. 2018 Apr;90(4):277-279. doi: 10.1016/j.diagmicrobio.2017.12.006. Epub 2017 Dec 17.
We compared the Sanger sequencing and the commercial INNO-LiPA® HBV assay for the routine detection of precore (PC) and basal core promoter (BCP) mutations of hepatitis B virus in chronically infected patients. The overall agreement rate between assays was 94.2% and 98.8% for the detection of PC and BCP mutations, respectively.
我们比较了桑格测序法和商业INNO-LiPA® HBV检测法,用于慢性感染患者中乙肝病毒前核心(PC)和核心启动子(BCP)突变的常规检测。两种检测方法在检测PC和BCP突变方面的总体一致率分别为94.2%和98.8%。